Showing results (311-320 of 736) with videos related to

Sort By:
Pageof 74
Neuro-Oncology Practice|March 18, 2024
Antidepressants and survival in glioma-A registry-based retrospective cohort studySonja Edström, Barbro Numan Hellquist, Maria Sandström, et al.
Neuro-Oncology Practice|March 18, 2024
Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant gliomaKatherine B Peters, Candice Alford, Amy Heltemes, et al.
Neuro-Oncology Practice|March 18, 2024
RT-PCR assay to detect FGFR3::TACC3 fusions in formalin-fixed, paraffin-embedded glioblastoma samplesLoudy P Priesterbach-Ackley, Joyce van Kuik, Bastiaan B J Tops, et al.
Neuro-Oncology Practice|March 18, 2024
Choreographed expansion of services results in decreased patient burden without compromise of outcomes: An assessment of the Ontario experienceKathryn Rzadki, Wafa Baqri, Olga Yermakhanova, et al.
Neuro-Oncology Practice|March 18, 2024
Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of AlbertaEgiroh Omene, Omar Abdel-Rahman, Eugene Batuyong, et al.
Neuro-Oncology Practice|March 18, 2024
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and olderChristina Stadler, Dorothee Gramatzki, Emilie Le Rhun, et al.
Neuro-Oncology Practice|September 16, 2024
Identifying research priorities and essential elements of palliative care services for people facing malignant brain tumors: A participatory co-design approachLiz Salmi, Shirley Otis-Green, Adam Hayden, et al.
Neuro-Oncology Practice|September 16, 2024
Disease burden and healthcare utilization in pediatric low-grade glioma: A United States retrospective study of linked claims and electronic health recordsSusan Zelt, Tabitha Cooney, Sandie Yu, et al.
Neuro-Oncology Practice|March 20, 2025
Brain tumors and fitness to drive: A review and multi-disciplinary approachMark Willy L Mondia, Edward K Avila, Jeffrey S Wefel, et al.
Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.
Pageof 74